(Q35181577)

7 August 2017

1 reference

title

Hemophilia: treatment options in the twenty-first century (English)

1 reference

7 August 2017

0 references

Mannucci PM

1

1 reference

7 August 2017

publication date

1 July 2003

1 reference

Journal of Thrombosis and Haemostasis

7 August 2017

published in

1 reference

7 August 2017

volume

1

1 reference

7 August 2017

issue

7

1 reference

7 August 2017

page(s)

1349-1355

1 reference

The hemophilias--from royal genes to gene therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

A new variant of Creutzfeldt-Jakob disease in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Treatment of hemophilia: recombinant factors only? No.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Long-term induction of immune tolerance after blockade of CD40-CD40L interaction in a mouse model of hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Advances toward gene therapy for hemophilia at the millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Gene therapy: promises and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Gene therapy: reality or myth for the global bleeding disorders community?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Efficient lentiviral transduction of liver requires cell cycling in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

B-CLL: is the enigma of disease heterogeneity about to be revealed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Transmission of prion diseases by blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Creutzfeldt-Jakob disease and blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Creutzfeldt-Jakob disease and blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00262.X

10.1046/J.1538-7836.2003.00262.X

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference